Jeff Yuan is a partner with PwC China and currently serves as the tax markets leader for the firm.

Jeff and his team provide cross-border tax advice to multinational companies (MNCs) in China and their overseas headquarters across major industries. Such experiences include helping MNCs design and implement sustainable cross-border transactions from China/APAC/global tax perspectives.

Jeff is a regular speaker on China and global tax and regulatory updates and trends for professional conferences and contributes frequently to professional publications on relevant subjects.

Jeff has a Master's in Business Taxation from the University of Minnesota and a Bachelor's in Accounting from Winona State University. Jeff is a member of the American Institute of Certified Public Accountants.

Eric Zheng is the President of the American Chamber of Commerce in Shanghai, responsible for supporting over 3,000 member companies in the Yangtze River Delta area. He has previously served on the board of AmCham Shanghai as a member, treasurer, secretary, vice chairman, and 2018-2019 chairman.

Eric had a long career with American International Group (AIG) with a series of executive positions that culminated in his service as President & CEO of AIG China. Before AIG, Eric worked for the U.S. Department of Commerce as the principal commercial officer at the U.S. Consulate in Guangzhou. Prior to relocating to China, Eric worked for PwC in the U.S. for many years as a management consultant. Eric holds several volunteer roles including the Greater China regional chair and a board director of the Committee of 100, a non-partisan organization of prominent Chinese Americans.

Allan is the Principal at Goal Advisory. He formerly served as President of Merck China and Managing Director of Merck’s Electronics business sector in China and was a member of Merck’s Electronics Leadership Team. As President of Merck China, he developed and drove growth strategies in this key country and built on the company’s 350-year presence and reputation.

Prior to that role, Mr. Gabor was the President of Asia Pacific for the biopharma business of the Merck Group and was also the President and CEO for the biopharma business in China. He was instrumental in expanding Merck’s Asian footprint with a series of investments, including establishing Merck’s new €170 million world-class pharmaceutical manufacturing facility located in Nantong as well as building an extensive network of collaborations with leading academic and medical institutions.

Prior to joining Merck, Mr. Gabor spent 25 years at Pfizer in leadership roles including Chairman and General Manager for China, and Regional President for North Asia, Russia, India, Turkey and Eastern Europe. Mr. Gabor successfully directed the launch of many of Pfizer's innovative medicines into China and opened the China Regional Investment Center and a state-of-the-art research and development center in Shanghai.

In recognition of his tireless contribution to Shanghai, Mr. Gabor has been awarded the Magnolia Award twice by the Shanghai municipal government. He holds a BA in Communications from the College of Wooster and pursued further education at the University of Tennessee and Harvard Business School.

Ms. Dorothy Ying Dong is the President of Starr International Investment Advisors (Asia) Limited and the Chairman of Starr Property & Casualty (China) Co., Ltd, responsible for the business operation, investment and development strategy in China for Starr Asia.

Ms. Dong Ying has been responsible for the establishment of Starr China Investment Platform since 2007 and focused on the healthcare investment fields. She has led the team and conducted investments in healthcare, technology, and insurance sectors, as well as Fund of Funds investments for more than 1.7 billion US dollars. Additionally, she has established a strong investment and industry ecosystem, resulting in excellent long-term performance returns through different economic cycles. Since 2014, she has served as Vice Chairman of Starr Insurance China and as the Chairman since 2020 after leading the acquisition of Dazhong Insurance.

Healthcare and technology are two of the fields in which Ms. Dong has extensive investments. Her investments include Techpool Bio, Buchang Pharma, Aidea Pharma, Gushengtang, Hanxi Hospitals, Nanyan Insurance, InnoCare, AkesoBio, Abbisko, Conmed, Boan Bio, Frontera, MegaRobo, Kuaishou, Kidswant, Huisuanzhang, JOVO Energy, and some other industry leaders, and establish close cooperative relationships with the entrepreneurial teams. As well as supporting and leading investments, Ms. Dong has also established strategic alliances with general partners to create a strong investment ecosystem, including Boyu, Yunfeng, Hew Horizon, Qiming, Sherpa, YuanBio, Long Hill, Hankang, Creacion, Quan, Eastern Bell, Sinovation, Ince, Gao Cheng, and some other leading funds.

Ms. Dong has over 25 years investment experiences. She has been working in many leading groups and serving as a member of the Bord of Directors or Advisory Board of many companies and investment funds. She has strong connections and resources in healthcare, insurance, finance, and technology fields, as well as related government authorities. Ms. Dong is the Founding Director and former Rotating Chairman of the China Medical and Health Industry Investment Forum of 50 (H50) and actively promoting the development of China's medical and health industry, as well as a Tutor of Tsinghua University School of Economics and Management (Tsinghua SEM) and an Executive Committee Member of China Children’s Development Fund, contributing to the progress of China's education and children's rights.

Prior to joining Starr, she served as a Vice President at AIG Global Investment Corp. (Shanghai) Ltd., a division of American International Group, Inc, focusing on private equity in the PRC, and as a Director at Anglo Chinese Finance Limited. She worked as an Analyst and Fund Manager for Atlas Fund at Rochdale Investment Management Company in New York. Prior to that, she worked for HSBC Corporate Finance (Asia) Limited and Credit Lyonnais Securities (Asia) Limited. Ms. Dong received Bachelor’s degree in law from Shanghai University (Fudan Sub-school) in the PRC, and MBA degree from McGill University, Canada. She was admitted as a CFA (Chartered Financial Analyst) and is a member of the Hong Kong Society of Financial Analysts and the CFA Institute.

Xiangwei is Asia President and an Executive Committee member of AptarGroup, a global leader in drug delivery, consumer product dispensing and material science solutions. She also serves as a non-executive director on the board of Oterra, a world leader in natural food colors headquartered in Denmark and is an advisor to EQT Group in Sweden.

Xiangwei holds a rich career of 30+ years spanning Pharma, Beauty, Personal Care, Food, and Nutraceutical industries at multinational companies, including 20+ years in Switzerland, China, and America for Roche and DSM before joining Aptar in 2018. Xiangwei is recognized as a visionary and dynamic leader, who prides herself in her ability to think and act cross-culturally and to find win-win solutions in even the most difficult situations.

Xiangwei is passionate about the development and advancement of women, young professionals, and youths in less economically developed areas. She is a senior advisor to sHero China and serves on the Board of Governors of Shanghai YZL Philanthropy Fund.

Xiangwei is a frequent speaker and panelist on topics such as Doing Business in China and US-China Business Relationships.

In December 2023, Xiangwei was interviewed at Aptar’s Suzhou facility, alongside US Ambassador to China Nicholas Burns, by CBS correspondent Lesley Stahl in her segment An American in China featuring Ambassador Burns. In the interview, Xiangwei spoke about her long term optimism on China’s economic development, especially in the healthcare and consumer goods sectors. The story was aired on CBS Sunday program 60 Minutes on February 25, 2024.

Xiangwei received her Bachelor of Economics from the University of International Business & Economics in Beijing and her EMBA from Columbia Business School in New York.

Ian Shih has served as President of Rockwell Automation China since July 2018, responsible for the overall business in mainland China, Taiwan and Hong Kong. He is the first Chinese president of Rockwell Automation China.

Ian Shih joined Rockwell Automation in 2008 and has accumulated rich cross-regional and cross-cultural management experience in China, North America, South America and Europe. After taking office as the president of China, Ian Shih led the team to actively promote the implementation of intelligent manufacturing in China and support the transformation and upgrading of China's industries.

Ian Shih holds a bachelor's degree in electrical engineering and a master's degree in manufacturing business management from Pennsylvania State University. In addition, Ian Shih was also selected as the country advisor of Expert Group of the Fourth Industrial Revolution Industry Alliance of the United Nations Industrial Development Organization(UNIDO) and Vice President of Intelligent Manufacturing Industry Association, Vice President of Shanghai Overseas Economic and Technological Promotion Association.

石安自2018年7月起担任罗克韦尔自动化中国区总裁，负责中国大陆、台湾和香港的整体业务。他是罗克韦尔自动化中国区首位华裔总裁。

石安自2008年加入罗克韦尔自动化，在中国、北美洲、南美洲和欧洲积累了丰富的跨地域、跨文化管理经验。就任中国区总裁后，石安带领团队积极推动智能制造在中国的落地，支持中国产业的转型升级。

石安拥有美国宾夕法尼亚州立大学电气工程学士学位以及制造业企业管理硕士学位。此外，石安还入选了联合国工业发展组织第四次工业革命产业联盟的“国别顾问专家组”并担任联盟的国别顾问，同时担任上海长三角智能制造产业促进中心副理事长、上海市智能制造产业协会副会长、上海市海外经济技术促进会副会长。